Curing Duchenne Muscular Dystrophy with a New Version of CRISPRTechnology NetworksThe UT Southwestern group had previously used CRISPR-Cas9, the original gene-editing system, to correct the Duchenne defect in a mouse model of the disease and in human c… Continue reading
Technology Networks |
Curing Duchenne Muscular Dystrophy with a New Version of CRISPR
Technology Networks “By either skipping a mutation region or precisely repairing a mutation in the gene, CRISPR–Cpf1-mediated genome editing not only corrects Duchenne muscular dystrophy mutations but also improves muscle contractility and strength,” said co-author Dr. |
Clinical Oncology News |
CAR Therapy Research Heats Up
Clinical Oncology News Boston—While checkpoint inhibitors may be stealing the cancer news spotlight these days, advances in chimeric antigen receptor–modified T–cell therapy (CAR therapy) also have immuno-oncology investigators excited. “Hopefully, we will see approvals for … Nanoparticles reprogram immune cells to fight cancerFred Hutch News Service Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatmentGeekWire Nanoparticles To Fight Cancer? Immune System Can Be Reprogrammed With Them, Researchers SayInternational Business Times |
Clinical Oncology News |
CAR Therapy Research Heats Up
Clinical Oncology News Boston—While checkpoint inhibitors may be stealing the cancer news spotlight these days, advances in chimeric antigen receptor–modified T–cell therapy (CAR therapy) also have immuno-oncology investigators excited. “Hopefully, we will see approvals for … Nanoparticles reprogram immune cells to fight cancerFred Hutch News Service Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatmentGeekWire Nanoparticles To Fight Cancer? Immune System Can Be Reprogrammed With Them, Researchers SayInternational Business Times |